Possible modulation of concurrent Parkinson’s disease in the management of metastatic GIST: a review of two cases
Parkinson’s disease is a chronic progressive neurodegenerative condition. It damages central nervous system dopaminergic but also serotonergic and noradrenergic pathways. There is no known cure, and no existing therapy has been proven to slow or reverse progress of the disease. Treatment aims to alleviate symptoms and preserve functional independence while minimising adverse affects.
Keywords Dopaminergic stimulation, motor symptoms, neuroprotection, neuroregeneration, Parkinson’s disease